ScoreCardiology

DAPT score (dual antiplatelet therapy beyond 1 year)

Estimates whether extending dual antiplatelet therapy beyond 12 months after PCI gives more ischaemic benefit than bleeding risk.

Updated 30 October 2026

When to use it

Patients with a coronary stent who have completed about 12 months of dual antiplatelet therapy without major ischaemic or bleeding events.

What it needs

  • AgeOptions: < 65 years · 65–74 years · ≥ 75 years
  • Current cigarette smokerYes or no
  • Diabetes mellitusYes or no
  • Myocardial infarction at index presentationYes or no
  • Prior PCI or prior myocardial infarctionYes or no
  • Paclitaxel-eluting stentYes or no
  • Stent diameter < 3 mmYes or no
  • Congestive heart failure or LVEF < 30 %Yes or no
  • Vein graft PCIYes or no

The points for each answer and the automatic total are in the app.

How to interpret it

DAPT score
ResultInterpretation
≤ 1Unfavourable balance for extended dual therapy
≥ 2Favourable balance for extended dual therapy

Practical tip

Only applies to patients who tolerated 12 months of dual therapy without bleeding or ischaemic events; it does not set the initial duration.

3 more practical tips in the app.

Reference

A support tool for healthcare professionals: it guides and does not replace clinical judgement.

Back to top